Sharps Tech (STSS) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 14, 2026. Each column of the statement tables below links to the filing it was taken from.
Sharps Tech (STSS) reported $204K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sharps Technology’s balance-sheet expansion is financed by capital inflows and investment activity, not by operating cash generation.
Assets rose from$7.3M in FY2024 to$269.1M in FY2025 as financing supplied$215.5M , so the apparent strengthening in leverage and liquidity reflects capitalization more than internally generated earnings. That financing was paired with$187.5M invested and operating cash flow of-$11.0M , indicating the enlarged asset base was assembled and deployed externally while operations remained cash-consuming.
The gap between FY2025’s
The current ratio moved from 0.6x in FY2024 to 4.0x in FY2025, indicating short-term flexibility replaced the prior tight position. Debt-to-equity fell from 2.7x to 0.0x, but that improvement coincided with financing inflows and equity expansion, signaling a changed capital structure rather than operating de-risking.
Financial Health Signals
Sharps Tech does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Sharps Tech scores 5.06, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($77.9M) relative to total liabilities ($4.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Sharps Tech passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
Sharps Tech reported a net loss of $282.5M while operations used $11.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Sharps Tech reported an operating loss of $269.7M against $417K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Sharps Tech generated $193K in revenue in Q1 2026.
Sharps Tech's EBITDA was -$86.2M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6487.5% from the same quarter a year earlier.
Sharps Tech reported -$86.2M in net income in Q1 2026. This represents a decrease of 4571.1% from the same quarter a year earlier.
Cash & Balance Sheet
Sharps Tech held $12.3M in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Sharps Tech's gross margin was -5.1% in Q1 2026, indicating the percentage of revenue retained after direct costs.
Sharps Tech's ROE was -48.2% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 67.3 percentage points from the same quarter a year earlier.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Sharps Tech invested $137K in research and development in Q1 2026. This represents an increase of 67.2% from the same quarter a year earlier.
Sharps Tech spent $1.6M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding.
Not reported for Q1 2026.
STSS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $193K | N/A | $84K | $223K | N/A | N/A | N/A | N/A |
| Cost of Revenue | $203K | N/A | $1.3M | $1.3M | N/A | N/A | N/A | N/A |
| Gross Profit | -$10K | N/A | -$1.2M | -$1.0M | N/A | N/A | N/A | N/A |
| R&D Expenses | $137K+67.2% | N/A | $152K+4.5% | $61K-65.9% | $82K-58.5% | N/A | $146K-35.3% | $180K-19.6% |
| SG&A Expenses | $5.1M+270.4% | N/A | $110.7M+5822.1% | $1.9M+9.9% | $1.4M-17.1% | N/A | $1.9M-12.4% | $1.7M-24.6% |
| Operating Income | -$86.3M-6223.1% | N/A | -$102.6M-4993.5% | -$3.0M-56.5% | -$1.4M+26.0% | N/A | -$2.0M+14.6% | -$1.9M+24.1% |
| EBITDA | -$86.2M-6487.5% | N/A | N/A | N/A | -$1.3M+20.6% | N/A | N/A | N/A |
| Interest Expense | $10K+101.6% | N/A | $68K+196.6% | $97K-90.3% | -$627K-3396.0% | N/A | -$71K-502.4% | $1.0M+2395.1% |
| Net Income | -$86.2M-4571.1% | N/A | -$105.3M-6151.0% | $3.6M+269.3% | $1.9M+296.3% | N/A | -$1.7M+16.7% | -$2.1M+19.3% |
| EPS (Basic) | -$1.19-103.1% | N/A | -$4.33-240.9% | $3.58+100.6% | $38.63+111.1% | N/A | -$1.27+66.3% | -$643.64-292663.6% |
| EPS (Diluted) | -$1.19 | N/A | -$4.33 | $3.58 | $38.63 | N/A | -$379.55 | -$643.64 |
| Diluted Shares (Avg) | 73M | N/A | 24M | 995,212 | 49,938 | N/A | 4,440 | 3,266 |
Not reported in any period shown, so not listed: Income Tax.
STSS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $181.0M+856.9% | $269.1M+3579.0% | $444.0M+3844.9% | $17.1M+72.0% | $18.9M+92.9% | $7.3M-38.0% | $11.3M-21.7% | $9.9M-15.8% |
| Current Assets | $18.4M+29.0% | $18.9M+494.9% | $39.7M+752.1% | $10.5M+197.2% | $14.2M+343.7% | $3.2M-34.4% | $4.7M-32.9% | $3.5M-14.1% |
| Cash & Equivalents | $12.3M+3.6% | $10.4M+1275.6% | $10.5M+325.4% | $8.3M+461.1% | $11.9M+920.2% | $755K-74.9% | $2.5M-55.5% | $1.5M-49.3% |
| Inventory | $458K-77.7% | $645K+19.8% | $745K-63.1% | $1.6M-13.5% | $2.1M+11.6% | $539K-68.5% | $2.0M+56.9% | $1.9M+90.0% |
| Accounts Receivable | $397K | N/A | N/A | $136K | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.2M-74.7% | $4.7M-11.7% | $10.7M+126.3% | $2.5M-6.2% | $8.8M+198.3% | $5.3M+37.9% | $4.7M+25.7% | $2.7M-12.6% |
| Current Liabilities | $2.2M-74.3% | $4.7M-9.5% | $10.6M+131.4% | $2.4M-5.5% | $8.6M+211.0% | $5.2M+40.4% | $4.6M+28.0% | $2.6M-12.4% |
| Non-Current Liabilities | $0-100.0% | $0-100.0% | $132K-18.5% | $132K-18.5% | $132K-18.5% | $132K-18.5% | $162K-15.6% | $162K-15.6% |
| Total Equity | $178.8M+1664.0% | $264.4M+13144.6% | $433.2M+6559.0% | $14.5M+101.5% | $10.1M+47.7% | $2.0M-74.8% | $6.5M-38.6% | $7.2M-16.9% |
| Retained Earnings | -$403.2M-1139.9% | -$316.9M-820.1% | -$134.3M-348.8% | -$29.0M-2.6% | -$32.5M-24.4% | -$34.4M-37.0% | -$29.9M-35.7% | -$28.2M-41.0% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill, Long-Term Debt.
STSS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.7M-88.8% | $753K-2.3% | -$7.4M-349.5% | -$2.9M-79.2% | -$1.4M+25.0% | $771K+132.6% | -$1.6M+18.4% | -$1.6M+20.7% |
| Depreciation & Amortization | $22K-59.5% | N/A | N/A | N/A | $55K-71.8% | N/A | N/A | N/A |
| Stock-Based Compensation | $2.2M+4924.9% | N/A | $3.3M+2742.3% | $28K-86.4% | $44K-64.9% | N/A | $116K | $202K |
| Capital Expenditures | N/A | N/A | $1.4M+2766.7% | $1.9M+11227.4% | $90K+3069.9% | $69K | $50K | $17K |
| Free Cash Flow | N/A | N/A | -$8.8M-421.3% | -$4.8M-190.3% | -$1.5M+20.3% | $702K | -$1.7M | -$1.7M |
| Investing Cash Flow | $9.3M+2061.1% | $2.0M+2747.1% | -$187.5M-372725.8% | -$1.5M-46.2% | -$474K-16507.9% | $70K+126.1% | -$50K+43.4% | -$1.0M-467.1% |
| Financing Cash Flow | -$4.7M-133.5% | $4.8M+2297.9% | $196.8M+7093.1% | $0-100.0% | $14.0M+3523392.7% | $199K | $2.7M-42.9% | $3.0M |
| Share Buybacks | $1.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
STSS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -5.1% | N/A | -1398.7% | -463.4% | N/A | N/A | N/A | N/A |
| Operating Margin | -44748.4% | N/A | -122747.9% | -1349.8% | N/A | N/A | N/A | N/A |
| Net Margin | -44734.5% | N/A | -125963.6% | 1598.1% | N/A | N/A | N/A | N/A |
| Return on Equity | -48.2%-67.3pp | N/A | -24.3%+1.6pp | 24.5%+53.6pp | 19.0%+33.4pp | N/A | -25.9%-6.8pp | -29.1%+0.9pp |
| Return on Assets | -47.6%-57.9pp | N/A | -23.7%-8.8pp | 20.8%+42.0pp | 10.2%+20.2pp | N/A | -15.0%-0.9pp | -21.2%+0.9pp |
| Current Ratio | 8.28+6.6x | 4.02+3.4x | 3.74+2.7x | 4.35+3.0x | 1.65+0.5x | 0.61-0.7x | 1.01-0.9x | 1.380.0x |
| Debt-to-Equity | 0.01-0.9x | 0.02-2.6x | 0.02-0.7x | 0.18-0.2x | 0.87+0.4x | 2.66+2.2x | 0.73+0.4x | 0.380.0x |
| Asset Turnover | 0.00 | N/A | 0.00 | 0.01 | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | -10559.0% | -2158.6% | N/A | N/A | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Sharps Tech STSS | FY2025 | $204K | -$282.5M | N/A | $77.9M | — |
| Orasure Tech OSUR | FY2025 | $115.0M | -$68.7M | -59.8% | $240.0M | 48/100 |
| Stereotaxis Ord STXS | FY2025 | $32.4M | -$21.6M | -66.8% | $139.3M | 42/100 |
| Infusystem Hld INFU | FY2025 | $143.4M | $6.6M | 4.6% | $243.8M | 60/100 |
| Utah Med Prods UTMD | FY2025 | $38.5M | $11.3M | 29.3% | $226.4M | 78/100 |
Where Sharps Tech Ranks
Frequently Asked Questions
What is Sharps Tech's annual revenue?
Sharps Tech (STSS) reported $204K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Sharps Tech profitable?
No, Sharps Tech (STSS) reported a net income of -$282.5M in fiscal year 2025.
What is Sharps Tech's EBITDA?
Sharps Tech (STSS) had EBITDA of -$269.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Sharps Tech's gross margin?
Sharps Tech (STSS) had a gross margin of 2.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Sharps Tech's return on equity (ROE)?
Sharps Tech (STSS) has a return on equity of -106.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Sharps Tech's operating cash flow?
Sharps Tech (STSS) recorded an outflow of $11.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Sharps Tech's total assets?
Sharps Tech (STSS) had $269.1M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Sharps Tech spend on research and development?
Sharps Tech (STSS) invested $199K in research and development during fiscal year 2025.
What is Sharps Tech's current ratio?
Sharps Tech (STSS) had a current ratio of 4.02 as of fiscal year 2025, which is generally considered healthy.
What is Sharps Tech's debt-to-equity ratio?
Sharps Tech (STSS) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Sharps Tech's return on assets (ROA)?
Sharps Tech (STSS) had a return on assets of -105.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Sharps Tech's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Sharps Tech (STSS) held $10.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $11.0M over that year. Dividing the one by the other, the reported balance equals about 11 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Sharps Tech's Altman Z-Score?
Sharps Tech (STSS) has an Altman Z-Score of 5.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Sharps Tech's Piotroski F-Score?
Sharps Tech (STSS) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Sharps Tech's earnings high quality?
Sharps Tech (STSS) reported a net loss of $282.5M while operations used $11.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Sharps Tech cover its interest payments?
Sharps Tech (STSS) reported an operating loss of $269.7M against $417K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.